scPharmaceuticals Inc. Logo

scPharmaceuticals Inc.

Develops drug-device combinations for outpatient care in cardiorenal conditions.

SCPH | US

Overview

Corporate Details

ISIN(s):
US8106481059
LEI:
Country:
United States of America
Address:
25 BURLINGTON MALL ROAD, SUITE 203, 1803 BURLINGTON

Description

scPharmaceuticals Inc. is a pharmaceutical company that develops and commercializes innovative solutions for outpatient care. The company specializes in drug-device combinations and therapies for cardiorenal conditions, including heart failure and chronic kidney disease. Its primary marketed product is FUROSCIX®, an FDA-approved on-body infuser for the subcutaneous administration of furosemide. This therapy is designed to treat fluid overload (edema) in adults with chronic heart failure, providing a convenient at-home alternative to intravenous treatments typically administered in a clinical setting.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-11-20 06:15 English ZIP 5.1 KB
2025-11-20 06:15 English ZIP 5.0 KB
2025-11-20 06:15 English ZIP 5.0 KB
2025-11-14 19:30 English ZIP 7.7 KB
2025-11-12 20:52 English ZIP 96.9 KB
2025-11-10 14:41 English ZIP 9.1 KB
2025-10-17 21:40
15-12G
English ZIP 8.0 KB
2025-10-14 22:10 English ZIP 11.0 KB
2025-10-08 23:02 English ZIP 8.2 KB
2025-10-07 22:30
4
English ZIP 8.8 KB
2025-10-07 22:30
4
English ZIP 8.0 KB
2025-10-07 22:30
4
English ZIP 8.0 KB
2025-10-07 22:30
4
English ZIP 8.2 KB
2025-10-07 22:30
4
English ZIP 8.1 KB
2025-10-07 22:30
4
English ZIP 9.0 KB

Automate Your Workflow. Get a real-time feed of all scPharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for scPharmaceuticals Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for scPharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.